Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 383

1.

Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial.

Younossi ZM, Ratziu V, Loomba R, Rinella M, Anstee QM, Goodman Z, Bedossa P, Geier A, Beckebaum S, Newsome PN, Sheridan D, Sheikh MY, Trotter J, Knapple W, Lawitz E, Abdelmalek MF, Kowdley KV, Montano-Loza AJ, Boursier J, Mathurin P, Bugianesi E, Mazzella G, Olveira A, Cortez-Pinto H, Graupera I, Orr D, Gluud LL, Dufour JF, Shapiro D, Campagna J, Zaru L, MacConell L, Shringarpure R, Harrison S, Sanyal AJ; REGENERATE Study Investigators.

Lancet. 2019 Dec 5. pii: S0140-6736(19)33041-7. doi: 10.1016/S0140-6736(19)33041-7. [Epub ahead of print]

PMID:
31813633
2.

Alcohol-related liver disease. Clinical practice guidelines. Consensus document sponsored by AEEH.

Bataller R, Cabezas J, Aller R, Ventura-Cots M, Abad J, Albillos A, Altamirano J, Arias-Loste MT, Bañares R, Caballería J, Caballería L, Carrión JA, Diago M, Fernández Rodríguez C, Gallego R, García-Cortes M, García-Monzón C, Genescà J, Ginés P, Hernandez-Guerra M, Jorquera F, Lligoña A, Molina E, Pareja MJ, Planas R, Tomé S, Salmerón J, Romero-Gómez M.

Gastroenterol Hepatol. 2019 Nov 23. pii: S0210-5705(19)30224-9. doi: 10.1016/j.gastrohep.2019.09.006. [Epub ahead of print] English, Spanish.

PMID:
31771785
3.

Oral glutamine challenge is a marker of altered ammonia metabolism and predicts the risk of hepatic encephalopathy.

Ampuero J, Gil A, Viloria MDM, Rico MC, Millán R, Camacho I, Romero-Gómez M.

Liver Int. 2019 Nov 15. doi: 10.1111/liv.14297. [Epub ahead of print]

PMID:
31729816
4.

[Carbapenem-producing Enterobacteriaceae bloodstream infection: Microbiology's role in their rapid detection].

Alonso Acero L, Gutiérrez Arroyo A, Ramos Ramos JC, Romero Gómez MP.

Rev Esp Quimioter. 2019 Oct 24. pii: alonso24oct2019. [Epub ahead of print] Spanish.

5.

qFIBS: A Novel Automated Technique for Quantitative Evaluation of Fibrosis, Inflammation, Ballooning, and Steatosis in Patients With Nonalcoholic Steatohepatitis.

Liu F, Goh GB, Tiniakos D, Wee A, Leow WQ, Zhao JM, Rao HY, Wang XX, Wang Q, Wan WK, Lim KH, Romero-Gomez M, Petta S, Bugianesi E, Tan CK, Harrison SA, Anstee QM, Jason Chang PE, Wei L.

Hepatology. 2019 Oct 10. doi: 10.1002/hep.30986. [Epub ahead of print]

PMID:
31600834
6.

A cross-sectional study of the public health response to non-alcoholic fatty liver disease in Europe.

Lazarus JV, Ekstedt M, Marchesini G, Mullen J, Novak K, Pericàs JM, Roel E, Romero-Gómez M, Ratziu V, Tacke F, Cortez-Pinto H, Anstee QM; EASL International Liver Foundation NAFLD Policy Review Collaborators.

J Hepatol. 2019 Sep 10. pii: S0168-8278(19)30521-5. doi: 10.1016/j.jhep.2019.08.027. [Epub ahead of print]

7.

Isolation of Candida in the blood cultures of patients admitted to the Emergency Room in a tertiary care hospital.

Falces-Romero I, Romero-Gómez MP, García-Rodríguez J, Cendejas-Bueno E.

Rev Iberoam Micol. 2019 Jul - Sep;36(3):142-146. doi: 10.1016/j.riam.2019.02.003. Epub 2019 Aug 1.

PMID:
31377147
8.

Noninvasive Tests Accurately Identify Advanced Fibrosis due to NASH: Baseline Data From the STELLAR Trials.

Anstee QM, Lawitz EJ, Alkhouri N, Wong VW, Romero-Gomez M, Okanoue T, Trauner M, Kersey K, Li G, Han L, Jia C, Wang L, Chen G, Subramanian GM, Myers RP, Djedjos CS, Kohli A, Bzowej N, Younes Z, Sarin S, Shiffman ML, Harrison SA, Afdhal NH, Goodman Z, Younossi ZM.

Hepatology. 2019 Nov;70(5):1521-1530. doi: 10.1002/hep.30842. Epub 2019 Aug 19.

PMID:
31271665
9.

Relationship Between Self-Perceived Health, Vitality, and Posttraumatic Growth in Liver Transplant Recipients.

Funuyet-Salas J, Martín-Rodríguez A, Borda-Mas M, Avargues-Navarro ML, Gómez-Bravo MÁ, Romero-Gómez M, Conrad R, Pérez-San-Gregorio MÁ.

Front Psychol. 2019 Jun 11;10:1367. doi: 10.3389/fpsyg.2019.01367. eCollection 2019.

10.

Development and Validation of Hepamet Fibrosis Scoring System A Simple, Noninvasive Test to Identify Patients With Nonalcoholic Fatty Liver Disease With Advanced Fibrosis.

Ampuero J, Pais R, Aller R, Gallego-Durán R, Crespo J, García-Monzón C, Boursier J, Vilar E, Petta S, Ming-Hua Z, Escudero D, Calleja JL, Aspichueta P, Diago M, Rosales JM, Caballería J, Gómez-Camarero J, Lo Iacono O, Benlloch S, Albillos A, Turnes J, Banales JM, Ratziu V, Romero-Gómez M; HEPAmet Registry.

Clin Gastroenterol Hepatol. 2019 Jun 11. pii: S1542-3565(19)30602-0. doi: 10.1016/j.cgh.2019.05.051. [Epub ahead of print]

PMID:
31195161
11.

Water-soluble extracts from edible mushrooms (Agaricus bisporus) as inhibitors of hepatitis C viral replication.

Gallego P, Rojas Á, Falcón G, Carbonero P, García-Lozano MR, Gil A, Grande L, Cremades O, Romero-Gómez M, Bautista JD, Del Campo JA.

Food Funct. 2019 Jun 19;10(6):3758-3767. doi: 10.1039/c9fo00733d.

PMID:
31179460
12.

The challenge of molecular diagnosis of bloodstream infections.

Cendejas-Bueno E, Romero-Gómez MP, Mingorance J.

World J Microbiol Biotechnol. 2019 Apr 2;35(4):65. doi: 10.1007/s11274-019-2640-y. Review.

PMID:
30941578
13.

Metabolic characterization of two different non-alcoholic fatty liver disease pre-clinical mouse models.

Gallego-Durán R, Álvarez-Amor L, Gil-Gómez A, Rojas Á, Muñoz-Hernández R, Cádernas-García A, Maya-Miles D, Montero-Vallejo R, Gato S, Sánchez Torrijos Y, Ampuero J, Martín F, Romero-Gómez M.

Rev Esp Enferm Dig. 2019 Apr;111(4):301-307. doi: 10.17235/reed.2019.6083/2018.

14.

Cardiotrophin-1 is an anti-inflammatory cytokine and promotes IL-4-induced M2 macrophage polarization.

Carneros D, Santamaría EM, Larequi E, Vélez-Ortiz JM, Reboredo M, Mancheño U, Perugorria MJ, Navas P, Romero-Gómez M, Prieto J, Hervás-Stubbs S, Bustos M.

FASEB J. 2019 Jun;33(6):7578-7587. doi: 10.1096/fj.201801563R. Epub 2019 Mar 20.

PMID:
30892966
15.

Analysis of the burden and variability in the management of NAFLD patients in the clinical practice: unifying the required criteria.

Sánchez-Torrijos Y, Ampuero J, Pérez Palacios D, Gallego-Durán R, Romero-Gómez M.

Rev Esp Enferm Dig. 2019 Apr;111(4):270-274. doi: 10.17235/reed.2019.6088/2018.

16.

Higher levels of serum uric acid influences hepatic damage in patients with non-alcoholic fatty liver disease (NAFLD).

Fernández Rodríguez CM, Aller R, Gutiérrez García ML, Ampuero J, Gómez-Camarero J, Martín-Mateos RMª, Burgos-Santamaría D, Rosales JM, Aspichueta P, Buque X, Latorre M, Andrade RJ, Hernández-Guerra M, Romero-Gómez M.

Rev Esp Enferm Dig. 2019 Apr;111(4):264-269. doi: 10.17235/reed.2019.5965/2018.

17.

Optimizing hot carrier effects in Pt-decorated plasmonic heterostructures.

Salmón-Gamboa JU, Romero-Gómez M, Roth DJ, Barber MJ, Wang P, Fairclough SM, Nasir ME, Krasavin AV, Dickson W, Zayats AV.

Faraday Discuss. 2019 May 23;214(0):387-397. doi: 10.1039/c8fd00150b.

PMID:
30801594
18.

Reduced Patient-Reported Outcome Scores Associate With Level of Fibrosis in Patients With Nonalcoholic Steatohepatitis.

Younossi ZM, Stepanova M, Anstee QM, Lawitz EJ, Wai-Sun Wong V, Romero-Gomez M, Kersey K, Li G, Subramanian GM, Myers RP, Djedjos CS, Okanoue T, Trauner M, Goodman Z, Harrison SA.

Clin Gastroenterol Hepatol. 2019 Nov;17(12):2552-2560.e10. doi: 10.1016/j.cgh.2019.02.024. Epub 2019 Feb 16.

PMID:
30779990
19.

Bacteremia caused by Herbaspirillum huttiense in a newborn.

Liras Hernández MG, Girón de Velasco Sada P, Falces Romero I, Romero Gómez MP.

Enferm Infecc Microbiol Clin. 2019 Aug - Sep;37(7):491. doi: 10.1016/j.eimc.2018.12.011. Epub 2019 Feb 13. English, Spanish. No abstract available.

PMID:
30770150
20.

Hepatic encephalopathy and traffic accidents: Vigilance is needed!

Tapper EB, Romero-Gómez M, Bajaj JS.

J Hepatol. 2019 Apr;70(4):590-592. doi: 10.1016/j.jhep.2019.01.017. Epub 2019 Feb 11. No abstract available.

PMID:
30765121
21.

Use of Steatotic Grafts in Liver Transplantation: Current Status.

Álvarez-Mercado AI, Gulfo J, Romero Gómez M, Jiménez-Castro MB, Gracia-Sancho J, Peralta C.

Liver Transpl. 2019 May;25(5):771-786. doi: 10.1002/lt.25430. Epub 2019 Apr 5. Review.

PMID:
30740859
22.

A variant in the MICA gene is associated with liver fibrosis progression in chronic hepatitis C through TGF-β1 dependent mechanisms.

Sharkawy RE, Bayoumi A, Metwally M, Mangia A, Berg T, Romero-Gomez M, Abate ML, Irving WL, Sheridan D, Dore GJ, Spengler U, Lampertico P, Bugianesi E, Weltman M, Mollison L, Cheng W, Riordan S, Santoro R, Gallego-Durán R, Fischer J, Nattermann J, D'Ambrosio R, McLeod D, Powell E, Latchoumanin O, Thabet K, Najim MAM, Douglas MW, Liddle C, Qiao L, George J, Eslam M; International Liver Disease Genetics Consortium (ILDGC).

Sci Rep. 2019 Feb 5;9(1):1439. doi: 10.1038/s41598-018-35736-2.

23.

Presentation and Outcomes of Pregnancy in Patients With Autoimmune Hepatitis.

Llovet LP, Horta D, Eliz MG, Berenguer M, Fábrega E, Sáez-Royuela F, García-Retortillo M, Torrijos YS, Romero-Gómez M, Fernández C, Domínguez EG, Parés A, Londoño MC.

Clin Gastroenterol Hepatol. 2019 Dec;17(13):2819-2821. doi: 10.1016/j.cgh.2018.12.030. Epub 2019 Jan 4.

PMID:
30616023
24.

Health-related Quality of Life in Nonalcoholic Fatty Liver Disease Associates With Hepatic Inflammation.

Huber Y, Boyle M, Hallsworth K, Tiniakos D, Straub BK, Labenz C, Ruckes C, Galle PR, Romero-Gómez M, Anstee QM, Schattenberg JM; EPoS Consortium Investigators.

Clin Gastroenterol Hepatol. 2019 Sep;17(10):2085-2092.e1. doi: 10.1016/j.cgh.2018.12.016. Epub 2018 Dec 20.

PMID:
30580090
25.

MALDI-TOF MS for rapid diagnosis of Anaerobiospirillum succiniciproducens, an unusual causative agent of bacteraemia in humans. Two case reports and literature review.

Alguacil-Guillen M, Ramos-Ruperto L, Ramos Ramos JC, Robles-Marhuenda A, García-Rodriguez J, Mingorance J, Romero-Gómez MP.

Anaerobe. 2019 Feb;55:130-135. doi: 10.1016/j.anaerobe.2018.12.003. Epub 2018 Dec 14.

PMID:
30557657
26.

Usefulness of bioelectrical impedance analysis for monitoring patients with refractory ascites.

Ontanilla-Clavijo G, Ampuero J, Borreguero S, Rosell J, Romero-Gómez M.

Rev Esp Enferm Dig. 2019 Mar;111(3):223-227. doi: 10.17235/reed.2018.5634/2018.

27.

A Pilot Study of Serum Sphingomyelin Dynamics in Subjects with Severe Obesity and Non-alcoholic Steatohepatitis after Sleeve Gastrectomy.

Ramos-Molina B, Castellano-Castillo D, Pastor O, Ocaña-Wilhelmi L, Fernández-García D, Romero-Gómez M, Cardona F, Tinahones FJ.

Obes Surg. 2019 Mar;29(3):983-989. doi: 10.1007/s11695-018-3612-2.

PMID:
30488259
28.

Effects of Alcohol Consumption and Metabolic Syndrome on Mortality in Patients With Nonalcoholic and Alcohol-Related Fatty Liver Disease.

Younossi ZM, Stepanova M, Ong J, Yilmaz Y, Duseja A, Eguchi Y, El Kassas M, Castellanos-Fernandez M, George J, Jacobson IM, Bugianesi E, Wong VW, Arrese M, de Ledinghen V, Romero-Gomez M, Mendez-Sanchez N, Ahmed A, Wong R, Papatheodoridis G, Serfaty L, Younossi I, Nader F, Ziayee M, Afendy A; Global NASH Council.

Clin Gastroenterol Hepatol. 2019 Jul;17(8):1625-1633.e1. doi: 10.1016/j.cgh.2018.11.033. Epub 2018 Nov 23.

PMID:
30476585
29.

A polymorphism in the Irisin-encoding gene (FNDC5) associates with hepatic steatosis by differential miRNA binding to the 3'UTR.

Metwally M, Bayoumi A, Romero-Gomez M, Thabet K, John M, Adams LA, Huo X, Aller R, García-Monzón C, Teresa Arias-Loste M, Bugianesi E, Miele L, Gallego-Durán R, Fischer J, Berg T, Liddle C, Qiao L, George J, Eslam M.

J Hepatol. 2019 Mar;70(3):494-500. doi: 10.1016/j.jhep.2018.10.021. Epub 2018 Oct 31.

PMID:
30389552
30.

The effects of metabolic status on non-alcoholic fatty liver disease-related outcomes, beyond the presence of obesity.

Ampuero J, Aller R, Gallego-Durán R, Banales JM, Crespo J, García-Monzón C, Pareja MJ, Vilar-Gómez E, Caballería J, Escudero-García D, Gomez-Camarero J, Calleja JL, Latorre M, Albillos A, Salmeron J, Aspichueta P, Lo Iacono O, Francés R, Benlloch S, Fernández-Rodríguez C, García-Samaniego J, Estévez P, Andrade RJ, Turnes J, Romero-Gómez M; HEPAmet Registry.

Aliment Pharmacol Ther. 2018 Dec;48(11-12):1260-1270. doi: 10.1111/apt.15015. Epub 2018 Oct 23.

PMID:
30353552
31.

Recommendations for Management and Treatment of Nonalcoholic Steatohepatitis.

Ratziu V, Ghabril M, Romero-Gomez M, Svegliati-Baroni G.

Transplantation. 2019 Jan;103(1):28-38. doi: 10.1097/TP.0000000000002483. Review.

PMID:
30300289
32.

Effectiveness and safety of elbasvir/grazoprevir therapy in patients with chronic HCV infection: Results from the Spanish HEPA-C real-world cohort.

Hernández-Conde M, Fernández I, Perelló C, Gallego A, Bonacci M, Pascasio JM, Romero-Gómez M, Llerena S, Fernández-Rodríguez C, Castro Urda JL, García Buey L, Carmona I, Morillas RM, García ND, Gea F, Carrión JA, Castellote J, Moreno-Planas JM, Piqueras Alcol B, Molina E, Diago M, Montoliu S, de la Vega J, Menéndez F, Sánchez Ruano JJ, García-Samaniego J, Rosales-Zabal JM, Anton MD, Badia E, Souto-Rodríguez R, Salmeron FJ, Fernández-Bermejo M, Figueruela B, Moreno-Palomares JJ, Calleja JL.

J Viral Hepat. 2019 Jan;26(1):55-64. doi: 10.1111/jvh.13008. Epub 2018 Oct 25.

PMID:
30265418
33.

A dynamically young and perturbed Milky Way disk.

Antoja T, Helmi A, Romero-Gómez M, Katz D, Babusiaux C, Drimmel R, Evans DW, Figueras F, Poggio E, Reylé C, Robin AC, Seabroke G, Soubiran C.

Nature. 2018 Sep;561(7723):360-362. doi: 10.1038/s41586-018-0510-7. Epub 2018 Sep 19.

PMID:
30232428
34.

Does the Antitumor Necrosis Factor-α Therapy Decrease the Vertebral Fractures Occurrence in Inflammatory Bowel Disease?

Maldonado-Pérez MB, Castro-Laria L, Caunedo-Álvarez A, Montoya-García MJ, Giner-García M, Argüelles-Arias F, Romero-Gómez M, Vázquez-Gámez MÁ.

J Clin Densitom. 2019 Apr - Jun;22(2):195-202. doi: 10.1016/j.jocd.2018.07.010. Epub 2018 Aug 13.

PMID:
30205986
35.

Peer-to-Peer Sessions in Primary Care to Improve the Hepatitis B Detection Rate in Seville, Spain.

Otero MÁ, Liu CH, Ampuero J, Llorca R, Vargas-Romero M, Romero-Gómez M.

Ann Hepatol. 2018 Aug 24;17(5):864-870. doi: 10.5604/01.3001.0012.3162.

36.

miRNAs in patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis.

Liu CH, Ampuero J, Gil-Gómez A, Montero-Vallejo R, Rojas Á, Muñoz-Hernández R, Gallego-Durán R, Romero-Gómez M.

J Hepatol. 2018 Dec;69(6):1335-1348. doi: 10.1016/j.jhep.2018.08.008. Epub 2018 Aug 22.

PMID:
30142428
37.

Primary biliary cholangitis in Spain. Results of a Delphi study of epidemiology, diagnosis, follow-up and treatment.

Parés A, Albillos A, Andrade RJ, Berenguer M, Crespo J, Romero-Gómez M, Vergara M, Vendrell B, Gil A.

Rev Esp Enferm Dig. 2018 Oct;110(10):641-649. doi: 10.17235/reed.2018.5665/2018. Review.

38.

Metabolomic-based noninvasive serum test to diagnose nonalcoholic steatohepatitis: Results from discovery and validation cohorts.

Mayo R, Crespo J, Martínez-Arranz I, Banales JM, Arias M, Mincholé I, Aller de la Fuente R, Jimenez-Agüero R, Alonso C, de Luis DA, Vitek L, Stritesky J, Caballería J, Romero-Gómez M, Martín-Duce A, Mugüerza Huguet JM, Busteros-Moraza JI, Idowu MO, Castro A, Martínez-Chantar ML, Ortiz P, Bruha R, Lu SC, Bedossa P, Noureddin M, Sanyal AJ, Mato JM.

Hepatol Commun. 2018 May 4;2(7):807-820. doi: 10.1002/hep4.1188. eCollection 2018 Jul.

39.

Preemptive-TIPS Improves Outcome in High-Risk Variceal Bleeding: An Observational Study.

Hernández-Gea V, Procopet B, Giráldez Á, Amitrano L, Villanueva C, Thabut D, Ibañez-Samaniego L, Silva-Junior G, Martinez J, Genescà J, Bureau C, Trebicka J, Llop E, Laleman W, Palazon JM, Castellote J, Rodrigues S, Gluud LL, Noronha Ferreira C, Barcelo R, Cañete N, Rodríguez M, Ferlitsch A, Mundi JL, Gronbaek H, Hernández-Guerra M, Sassatelli R, Dell'Era A, Senzolo M, Abraldes JG, Romero-Gómez M, Zipprich A, Casas M, Masnou H, Primignani M, Krag A, Nevens F, Calleja JL, Jansen C, Robic MA, Conejo I, Catalina MV, Albillos A, Rudler M, Alvarado E, Guardascione MA, Tantau M, Bosch J, Torres F, Garcia-Pagán JC; International Variceal Bleeding Observational Study Group and Baveno Cooperation.

Hepatology. 2019 Jan;69(1):282-293. doi: 10.1002/hep.30182. Epub 2018 Dec 10.

40.

Erratum to «Consensus document. Management of non-alcoholic fatty liver disease (NAFLD). Clinical practice guideline» [Gastroenterol Hepatol. 2018;41(5):328-349].

Aller R, Fernández-Rodríguez C, Lo Iacono O, Bañares R, Abad J, Carrión JA, García-Monzón C, Caballería J, Berenguer M, Rodríguez-Perálvarez M, López Miranda J, Vilar-Gómez E, Crespo J, García-Cortés M, Reig M, Navarro JM, Gallego-Durán R, Genescà J, Arias-Loste MT, Pareja MJ, Albillos A, Muntané J, Jorquera F, Solà E, Hernández-Guerra M, Rojo MÁ, Salmerón J, Caballería L, Diago M, Molina E, Bataller R, Romero-Gómez M.

Gastroenterol Hepatol. 2018 Aug - Sep;41(7):475-476. doi: 10.1016/j.gastrohep.2018.05.011. English, Spanish. No abstract available.

PMID:
29929828
41.

Nonalcoholic Steatohepatitis Is the Fastest Growing Cause of Hepatocellular Carcinoma in Liver Transplant Candidates.

Younossi Z, Stepanova M, Ong JP, Jacobson IM, Bugianesi E, Duseja A, Eguchi Y, Wong VW, Negro F, Yilmaz Y, Romero-Gomez M, George J, Ahmed A, Wong R, Younossi I, Ziayee M, Afendy A; Global Nonalcoholic Steatohepatitis Council.

Clin Gastroenterol Hepatol. 2019 Mar;17(4):748-755.e3. doi: 10.1016/j.cgh.2018.05.057. Epub 2018 Jun 14.

PMID:
29908364
42.

Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016-2030.

Estes C, Anstee QM, Arias-Loste MT, Bantel H, Bellentani S, Caballeria J, Colombo M, Craxi A, Crespo J, Day CP, Eguchi Y, Geier A, Kondili LA, Kroy DC, Lazarus JV, Loomba R, Manns MP, Marchesini G, Nakajima A, Negro F, Petta S, Ratziu V, Romero-Gomez M, Sanyal A, Schattenberg JM, Tacke F, Tanaka J, Trautwein C, Wei L, Zeuzem S, Razavi H.

J Hepatol. 2018 Oct;69(4):896-904. doi: 10.1016/j.jhep.2018.05.036. Epub 2018 Jun 8.

43.

Fibrosis Severity as a Determinant of Cause-Specific Mortality in Patients With Advanced Nonalcoholic Fatty Liver Disease: A Multi-National Cohort Study.

Vilar-Gomez E, Calzadilla-Bertot L, Wai-Sun Wong V, Castellanos M, Aller-de la Fuente R, Metwally M, Eslam M, Gonzalez-Fabian L, Alvarez-Quiñones Sanz M, Conde-Martin AF, De Boer B, McLeod D, Hung Chan AW, Chalasani N, George J, Adams LA, Romero-Gomez M.

Gastroenterology. 2018 Aug;155(2):443-457.e17. doi: 10.1053/j.gastro.2018.04.034. Epub 2018 May 5.

PMID:
29733831
44.

Diagnostic accuracy of SCCA and SCCA-IgM for hepatocellular carcinoma: A meta-analysis.

Liu CH, Gil-Gómez A, Ampuero J, Romero-Gómez M.

Liver Int. 2018 Oct;38(10):1820-1831. doi: 10.1111/liv.13867. Epub 2018 May 22.

PMID:
29704434
45.

Consensus document. Management of non-alcoholic fatty liver disease (NAFLD). Clinical practice guideline.

Aller R, Fernández-Rodríguez C, Lo Iacono O, Bañares R, Abad J, Carrión JA, García-Monzón C, Caballería J, Berenguer M, Rodríguez-Perálvarez M, Miranda JL, Vilar-Gómez E, Crespo J, García-Cortés M, Reig M, Navarro JM, Gallego R, Genescà J, Arias-Loste MT, Pareja MJ, Albillos A, Muntané J, Jorquera F, Solà E, Hernández-Guerra M, Rojo MÁ, Salmerón J, Caballería L, Diago M, Molina E, Bataller R, Romero-Gómez M.

Gastroenterol Hepatol. 2018 May;41(5):328-349. doi: 10.1016/j.gastrohep.2017.12.003. Epub 2018 Apr 7. English, Spanish. Erratum in: Gastroenterol Hepatol. 2018 Aug - Sep;41(7):475-476.

PMID:
29631866
46.

Metformin modifies glutamine metabolism in an in vitro and in vivo model of hepatic encephalopathy.

Gil-GÓmez A, Gómez-Sotelo AI, Ranchal I, Rojas Á, García-Valdecasas M, Muñoz-Hernández R, Gallego-Durán R, Ampuero J, Romero Gómez M.

Rev Esp Enferm Dig. 2018 Jul;110(7):427-433. doi: 10.17235/reed.2018.5004/2017.

47.

Natural Extracts Abolished Lipid Accumulation in Cells Harbouring non-favourable PNPLA3 genotype.

Rojas Á, Gallego P, Gil-Gómez A, Muñoz-Hernández R, Rojas L, Maldonado R, Gallego R, García-Valdecasas M, Del Campo JA, Bautista JD, Romero-Gómez M.

Ann Hepatol. 2018 Mar 1;17(2):242-249. doi: 10.5604/01.3001.0010.8642.

48.

Editorial: looking for patients at risk of cirrhosis in the general population-many needles in a haystack.

Ampuero J, Romero-Gómez M.

Aliment Pharmacol Ther. 2018 Mar;47(5):692-694. doi: 10.1111/apt.14517. No abstract available.

49.

Simvastatin and metformin inhibit cell growth in hepatitis C virus infected cells via mTOR increasing PTEN and autophagy.

Del Campo JA, García-Valdecasas M, Gil-Gómez A, Rojas Á, Gallego P, Ampuero J, Gallego-Durán R, Pastor H, Grande L, Padillo FJ, Muntané J, Romero-Gómez M.

PLoS One. 2018 Jan 31;13(1):e0191805. doi: 10.1371/journal.pone.0191805. eCollection 2018.

50.

Duration of the acute hepatic encephalopathy episode determines survival in cirrhotic patients.

Ventura-Cots M, Carmona I, Moreno C, Ampuero J, Simón-Talero M, Sanpedro F, Les I, Romero-Gómez M, Genescà J.

Therap Adv Gastroenterol. 2017 Nov 26;11:1756283X17743419. doi: 10.1177/1756283X17743419. eCollection 2018.

Supplemental Content

Loading ...
Support Center